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SUMMAry
head and neck squamous cell carcinoma of the (hnSCC) represents approximately 5% of malignant tumours in italy. hnSCC are com-
monly treated with surgery or radiotherapy, or a combination of such therapies. The objectives of treatment are maximum cure rate balanced 
with organ preservation, restoration of form and function, reduction of morbidities and improvement or maintenance of the patient’s quality 
of life. immediate reconstructive surgery: local, regional or free flaps are now widely advised in the treatment of these patients. Microsurgi-
cal transfer requires expertise, is time and resource consuming, and as a whole requires substantial costs. These considerations introduce 
some concerns about the wide or indiscriminate use of free flap reconstructive surgery. When considering cost-benefit outcomes of such 
treatment, the main objective is undoubtedly, survival. This data is underreported in the current literature, whereas functional outcomes of 
free flaps have been largely diffused and accepted. This study collects data from 1178 patients treated with free flap reconstructive surgery 
following ablation of hnSCC in a group of italian tertiary hospitals, all members of the head & neck group affiliated with the italian 
Society of Microsurgery. According to many authors, free flap surgery for hnSCC seems to be a beneficial option for treatment even in 
terms of survival.
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riASSUnTo
I tumori spinocellulari del distretto Cervico Facciale rappresentano circa il 5% dei tumori maligni in Italia. Essi sono comunemente trat-
tati con chirurgia o radioterapia, o entrambi le terapie. La ricostruzione rappresenta un momento fondamentale della terapia nel rispetto 
della qualità di vita di questi pazienti. La microchirurgia ricostruttiva rappresenta la tecnica che offre i migliori risultati funzionali ma 
è oggetto di discussione in un rapporto costo-benefici. In questo lavoro sono raccolti ed analizzati i dati di 1178 pazienti provenienti dai 
membri del gruppo testa e collo, affiliato alla società Italiana di Microchirurgia, e i cui dati sono rapportati primariamente alla sopravvi-
venza. 
pArole ChiAve: Tumori cervico-facciali • Lembi liberi • Sopravvivenza
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Introduction
Head and neck squamous cell carcinoma (HNSCC) rep-
resents approximately 5% of malignant tumours in Italy. 
Well-recognised or suspected aetiological agents for most 
HNSCC occurrences are alcohol and tobacco consump-
tion, oral lichen, misfit of prosthetic devices and comor-
bidities. Recently, human papilloma viruses have been 
causally associated with some oropharyngeal cancers  1. 
According to the site of origin, HNSCC are commonly 
treated with surgery or radiotherapy, either alone or in 
combination; medical therapy (i.e. cytotoxic drugs, mon-
oclonal antibodies) is often associated. The objectives of 
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such treatment are maximum cure rate balanced with or-
gan preservation, restoration of form and function, reduc-
tion of morbidities and improvement or maintenance of 
the patient’s quality of life. 
Immediate reconstructive surgery is now widely advised 
in these patients. Local or regional flaps have a definite 
role in limited lesions and specific situations. Simple or 
composite free flaps allow anatomical repair of almost all 
defects after HNSCC ablation, whereas functional recov-
ery is not always a guaranteed consequence of reconstruc-
tion. Microsurgical transfer requires expertise, is time and 
resource consuming, and as a whole implies significant 
costs 2. These points introduce some concerns about wide 
or indiscriminate use of this technique. Mücke et al. 3 re-
mark that some authors advocate that free flap reconstruc-
tion should be reserved to selected patients, namely those 
who are believed to have a better prognosis. Patients af-
fected by local advanced-stage tumours have worse prog-
nosis, but quite often they are those requiring an adequate 
reconstruction following extensive ablation 4: in terms of 
cost-benefit analysis, these patients should receive few-
er benefits from such complex surgery. However, when 
considering cost-benefit outcomes of such treatment, the 
main objective is, undoubtedly, survival. This data is un-
derreported in the current literature, whereas functional 
outcomes of free flaps have been largely diffused and ac-
cepted 5 11.
The aim of this study is analysis of survival data in pa-
tients treated with free flaps following ablation of HN-
SCC in a group of Italian tertiary hospitals, all of which 
are members of the Head & Neck Group affiliated with 
the Italian Society of Microsurgery.
Materials and methods
Patients
Patients were recruited from centres indicated in Table I. 
Each participating centre was responsible for reviewing 
charts and collecting their own data in a database specifi-
cally constructed for this study. The study period spanned 
from the date in which free flap surgery was introduced in 
each hospital up to December, 31, 2008.
Only patients with demonstrated HNSCC were consid-
ered eligible for this case study, and those affected by 
other malignancies (i.e. sarcomas, malignant melanoma, 
salivary tumours, etc.) were deliberately excluded, in or-
der to reduce the variability of prognostic factors. A mul-
ticentre study was proposed to acquire a larger quantity of 
cases available for analysis and a joint, elementary data-
base was formed.
Subjects were included irrespective of being a candi-
date to free flap surgery as part of primary treatment or 
salvage surgery (Table II, including basic demographic 
data). All patients who underwent neoadjuvant chemo-
therapy were assigned to the previously untreated group; 
Table I. Participating Centres.
Name of Centre
Istituto Nazionale Tumori, Milan
Clinica ORL, Università di Pavia, Pavia
Istituto Europeo di Oncologia, Milan
Clinica ORL, Università di Brescia
Clinica ORL, Università di Bologna
Ospedale Martini, Torino
Ospedale San Giuseppe, Milan
Ospedale Forlanini, Roma
Chirurgia Maxillo-Facciale, Università di Milano-Bicocca
Clinica ORL, Università di Ferrara
Table II. Patient characteristics (N = 1178).
Characteristics Value (%)
Age, years
 Median 58
 Range 17-85
Gender
 Male 851 (72.2)
 Female 327 (27.8)
Previous treatment
 NO 791 (66.3)
 Recurrence 397 (33.7)
Margins
 Clear 958 (81.3)
 Involved 220 (18.7)
Site
 Oral cavity 842 (71.5)
 Larynx-hypopharynx 188 (16.0)
 Pharynx 83 (7.0)
 Cranio-maxillo-facial 65 (5.5)
pT
pT0/pTx 33 (2.8)
pT1 51 (4.3)
pT2 349 (29.6)
pT3 165 (14.0)
pT4 580 (49.2)
pN
 N0 559 (47.5)
 N+ 557 (47.3)
 Nx 62 (5.2)
Adjuvant therapy
 NO 557 (47.3)
 RT 434 (36.8)
 CT+RT 133 (11.3)
 CT 33 (2.8)
 Na 21 (1.8)
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for any other preoperative treatment patients had re-
ceived despite the circumstance, they were attributed to 
the salvage surgery group.
All reconstructions were performed at the same ablative 
episode and, whenever possible, a two-team approach 
was used.
Due to the number of subsites of tumour origin, some 
data dispersion would have been expected, and therefore 
only major categories were considered and subjects were 
grouped according the main affected site (Table II). Simi-
lar belief about pT stratification (Table  II) led us to not 
consider it in survival analysis. 
All subjects were treated with curative intent with the aim 
of complete surgical ablation. Clearance of resection mar-
gins (involved or close to less than 5 mm were consid-
ered adverse event), pathological nodal status (any pN+ 
was defined as an adverse event) and adjuvant treatment, 
all recognised important prognostic factors, were also re-
corded and analysed.
Flap type and success rate were also investigated, but data 
were not reported as they were considered beyond the 
scope of this study.
The survival duration period was defined as the interval 
from surgery (see above) and the day of death from cancer 
or the end of follow-up (disease-specific survival, DSS).
Data analysis
Data from each participating hospital were compiled in 
a single database by appending them. Statistical analysis 
was performed with the software WinStat® for Excel (R. 
Fitch Software, Staufen, Germany).
The analysis was conducted according to the “intention 
to treat” method. Subsequently, the “worst-case scenario” 
(i.e. adverse event) was assumed when one of the follow-
ing conditions occurred: patient lost to follow up within 
2 years from surgery, in the case of “not evident disease” 
(NED) at the last update; patient still under control and 
in the case of “not evident disease” (NED) at the last up-
date, but whose follow up period was shorter than 2 years; 
perioperative (within 30 days from surgery) deaths were 
included in the analysis and were, of course, labelled as 
an adverse event.
A 5-year DSS was used as the dependent variable and cal-
culated according to the Kaplan-Meier method.
Possible predictor variables associated with DSS were: 
gender, previous treatment, site, clear margins, pathologi-
cal nodal status and adjuvant therapy. Significant variation 
among groups was investigated by the log-rank test and 
qualitative variables were evaluated using a non-parametric 
test (Chi square test). DSS, instead of overall survival, was 
chosen as it better depicts the natural history of HNSCC.
Multiple Cox proportional hazards regression models 
were conducted to explore the relationship between sur-
vival and variables believed to affect outcome.
Results
A total of 1178 patients met the criteria for eligibility; 
most had advanced loco-regional disease (Table  II). 
Clear margins were obtained in 958 cases (81.3%). The 
ability to achieve complete resection did not strictly cor-
relate to previous treatment (p = 0.06). Monolateral or 
bilateral neck dissection were part of the treatment in 
1116 (94.7%) cases. Pathological examination revealed 
that 559 (50.1%) patients had some degree of nodal in-
volvement. A total of 551 (46.8%) patients developed 
recurrence after free flap surgery: of these, 22 (4.0%) 
were salvaged. Perioperative deaths occurred in 19 cases 
(1.6%). The mean and median DSS were 44.4 and 30.6 
months, respectively. The probability of 5-year DSS is 
shown in Figure 1.
The possible influence of known prognostic factors was 
investigated. The probability of 5-year DSS according 
to sex, primary tumour region, margins of resection and 
adjuvant therapy are shown in Figure 2 (A, B, C, D) , to 
previous treatment in Figure 3 and to pathological nodal 
status in Figure 4.
Patients who were operated due to recurrence did worse 
than those of first observation, (including 48 patients who 
received neoadjuvant chemotherapy): their chances were 
43.1% and 54.1%, respectively (p < 0.001). Considering 
the completeness of resection, a higher rate was obtained 
in the primary treatment than the relapsing group, even 
though the difference did not reach statistical significance 
(p = 0.060739). On the other hand, the primary treat-
ment group had more pN positive cases than the relapsing 
group (p = 0.03285).
Involvement of regional nodes also negatively affected the 
outcome (40.5% vs. 62.9%, p < 0.001). Sex, age, mar-
gins of resection and adjuvant therapy were not associated 
with survival.
Fig. 1. Disease-specific survival calculated according to the Kaplan-Meier 
method.
P. Salvatori et al.
102
A Cox proportional hazard regression model analysis was 
conducted, controlling for sex, age, primary tumour re-
gion, previous treatment, margins of resection, pathologi-
cal nodal status and adjuvant therapy. Female gender, pre-
vious treatment and pathologically positive nodes were 
associated with worse prognosis. The hazard ratios were 
1.2, 1.6 and 1.9, respectively (Table III).
Discussion
Free flaps allow a wide range of quality and shape of tis-
sues that can be used for complex anatomical and func-
tional reconstructions. Disadvantages include expertise 
and higher costs of execution. This has to be taken into 
account when allocating resources, both at central (i.e. 
Fig. 2. The probability of 5-year DSS according to sex, primary tumour region, margins of resection and adjuvant therapy calculated according to the Kaplan-
Meier method.
Fig. 3. The probability of 5-year DSS according to previous treatment cal-
culated according to the Kaplan-Meier method.
Fig. 4.  The probability of 5-year DSS according to pN calculated according 
to the Kaplan-Meier method.
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health authority) and local (i.e. hospital or department) 
levels 2, particularly considering the limited economic re-
sources available. This might lead to selection of patients 
who are suitable candidates for free flap reconstruction: 
while excellent functional results with free flap surgery for 
HNSCC have been widely demonstrated 5-11, limited data 
are available concerning survival of these patients. This 
study was designed to depict an actual, panoramic view 
of free flap surgery for HNSCC. Intentionally, only a few, 
well defined prognostic factors were taken into account.
Inclusion criterion was limited to SCC because this ac-
counts for about 90% of head and neck malignancies: the 
large prevalence of SCC would allow building up a large 
series, whose analysis is more likely to produce signifi-
cant results. Indeed, this paper presents the largest series 
to date on this subject.
A multicentre study was proposed to acquire a larger 
quantity of cases available for analysis. Possible biases 
might have derived from different treatment policies, or 
expertise among the participating hospital. We tried to re-
duce these by involving centres that share basic principles 
of treatment and by building a joint, elementary database.
No patients were excluded from the survival analysis, and 
those lost to follow-up were considered under the most 
pessimistic hypothesis.
Five-year DSS of the whole series was 50.4%. Sites of 
tumour origin were grouped in four arbitrary regions: oral 
cavity (OC), pharynx (PH), larynx-hypopharynx (LH) 
and cranio-maxillo-facial (CMF), considering that each 
region poses particular tasks in terms of approach, resec-
tion and reconstruction. Survival was worse (27.2%) in 
patients suffering from CMF tumours than other areas 
(PH = 65.5%, LH = 54.5%, OC = 49.7).
Gender and age did not correlate with survival. The medi-
cal literature alternatively affirms or denies such a correla-
tion, and as such a conclusive statement seems unlikely.
Patients operated on because of relapsing tumour had low-
er 5-year DSS than those of the first observation (43.1% 
and 54.1%, respectively, p < 0.001). Differences between 
these groups with regards to completeness of resection 
and pathological N status confirms that local control re-
mains the main goal: it also seems reasonable to suppose 
relapsing cancers have more aggressive local behaviour 
that, in turn, carries worse prognosis.
The incomplete resection rate was 18.7%, which is quite 
disappointing since it does not fulfill the hypothesis that 
availability of outstanding flaps should allow wider and 
safer resections. The ability of achieving complete re-
section slightly correlated with previous treatment (p = 
0.060739). Indeed, one could theorise that resection of 
previously untreated cancer would be easier as the sur-
geon operates in a relatively unaltered field and chances 
of microscopically free margins would be greater than in 
a disordered anatomical set. However, 5-year DSS was 
similar between the groups with or without clear margins 
(51.0% vs. 47.3%, p = 0.14895). It is widely accepted that 
adjuvant therapy increases chances of survival. Patients 
with involved margins were ipso facto all candidates for 
some adjuvant therapy, when feasible (167/220, 75.9%), 
whereas patients with clear margins underwent adjuvant 
therapy less frequently (433/958, 45.2%). We suppose ad-
juvant radiotherapy improved survival in both groups by 
the same rate, but the impact was reasonably more evident 
for the involved margins group, as a higher proportion of 
patients underwent this treatment; this is a possible expla-
nation of the minimal, not statistically significant differ-
ence between the two DSS curves.
Pathological nodal status is a powerful, largely independ-
ent prognostic factor. This study confirms this data: pN-
negative patients did significantly better than pN-positive 
ones (62.8% vs. 40.6%; p < 0.001). Nodal metastases are 
thought to be an expression of intrinsic tumour offensive-
ness, whose treatment requires an aggressive approach (i.e. 
combined therapy): data from the present series lead us to 
suppose adjuvant therapy was only partially able to fill the 
survival gap between pN-negative and pN-positive patients.
Survival data, to our knowledge, can only be compared to 
the 32% reported by Podrecca et al 11. In that series there 
was a significant proportion (27.2%) of advanced tumours 
affecting the cranio-maxillo-facial (CMF) region, com-
monly believed to carry a poor prognosis, whereas in the 
present series tumours from CMF region accounted only 
for 5.5%: thus, the prognostic negative impact on the whole 
series is weakened. This seems a sustainable, even partial, 
explication of the difference between the two series.
Despite the lack of studies fully comparable to the pre-
sent one, there is some published data concerning survival 
after free flaps for HNSCC. Lidman and Niklasson 12 re-
ported the results of free flap surgery in primary intraoral 
SCC group of 79 patients, most in stage I (42%); they 
found a 5-year, tumour related, survival of 58%. Hana-
sono et al.  13 reviewed a group of previously untreated, 
T3-T4, oral SCC forming two subsets: patients operated 
without free flaps and with reconstruction (of whom, 66% 
were free flaps). The first group included a lower rate of 
advanced tumours than the reconstructed group. They re-
ported a 5-year overall survival (OS) of 37% in the latter 
subset and no difference with the non-reconstructed pa-
tients (42% OS): incompleteness of resection decreased 
Table III. Cox regression analysis.
Characteristics P value HR
Gender F 0.4 1.2
Recurrence < 0.001 1.6
pN+ < 0.001 1.9
Age 0.75
Involved margins 0.19
Adjuvant therapy 0.4
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from 18% to 7%, but no positive impact was demonstrat-
ed on survival or local relapse.
Kostrzewa et al. 14, in a series of recurrent oral and oro-
pharyngeal SCC including a large proportion of stage III-
IV tumours, reported a 5-year disease-specific survival of 
43.7%. Staging, margins and previous treatment were not 
associated with survival. On the other hand, pathological-
ly-affected nodes, short interval between primary treat-
ment and salvage surgery (or between salvage surgery and 
relapse) were important negative prognostic factors.
Finally, Mücke et al. 3 have recently described their expe-
rience on 274 oral cavity SCC patients operated on with 
free flaps, comparing them with 499 patients from the same 
institution, but treated without reconstruction or local/
regional flaps. The overall incomplete resection rate was 
17.5% (specific data for each group were not reported). Pa-
tients with involved margins or relapse within six months 
from treatment were excluded from the survival analysis. 
Relapse rate was similar within the two groups. Five-year 
overall survival was 66.2% in the free flap subset and 58.8% 
in the no free flap subset. Clinical T and N stage, grading, 
age and free flap were identified as prognostic factors in 
both univariate and multivariate analysis. The matched-pair 
analysis showed better survival in the free flap group, but 
limited to T3-4 stage patients (no difference for T1-2).
Conclusions
This study investigates the quoad vitam outcome of a large 
(the largest, to our knowledge) series of HNSCC patients 
treated with free flaps. Efforts were made to depict the ac-
tual setting that the Head & Neck surgeon faces in his/her 
daily activity (limited exclusion criteria, “worst-case sce-
nario” survival analysis). Survival rates are comparable, if 
not somewhat better, to those reported by different authors 
worldwide. Free flap surgery seems to have extended the 
concept of resectability, even if incompleteness of resec-
tion remains a pitfall (whose impact on survival appears 
to be uncertain). Salvage surgery has poorer results than 
primary surgery. Nodal involvement significantly decreas-
es chances of survival. According to many authors, free 
flap surgery for HNSCC seems to be a beneficial option 
of treatment even in terms of survival. Further research is 
planned to refine the survival analysis. This, in turn, would 
help both to optimize surgical indications and to compare 
results to those obtainable from other therapies (i.e. chem-
oradiation for oro-pharyngeal SCC).
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